Home › Companies › Avadel Pharmaceuticals plc › 2025-2026

Avadel Pharmaceuticals plc 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Avadel Pharmaceuticals plc’s Form 8-K, filed 2026-01-12 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 18Reported items
  • 229Asset managers
  • 1,763Fund votes
  • 2026-01-12Main meeting date

Proxy season: 2024-2025 2025-2026

Explore Avadel Pharmaceuticals plc in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Avadel Pharmaceuticals plc

These tallies are Avadel Pharmaceuticals plc’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-01-12 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Avadel Pharmaceuticals plc — official shareholder meeting results, meeting held 2026-01-12
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Proposal 1: To approve the Scheme 61,861,3521,646,857160,443 ---- Majority: yes
Proposal 2: To amend the Articles of Association of Avadel so that any ordinary shares of Avadel that are issued on or after the voting record time to persons other than Alkermes or its nominee(s) will either be subject to the Scheme or will be immediately and 61,808,6902,673,461377,282 ---- Majority: yes
Proposal 3: To approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Acquisition 55,489,0418,757,025613,367 ---- Majority: yes

Source: Avadel Pharmaceuticals plc, Form 8-K, filed with the SEC on 2026-01-12 — read the filing on EDGAR.

How asset managers voted at the Avadel Pharmaceuticals plc 2025-2026 meetings

Each item below shows how the 229 asset managers that disclosed a Avadel Pharmaceuticals plc vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Avadel Pharmaceuticals plc’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. ORDINARY RESOLUTION TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, SPECIFIED COMPENSATORY ARRANGEMENTS BETWEEN AVADEL AND ITS NAMED EXECUTIVE OFFICERS RELATING TO THE TRANSACTION.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2026-01-12.

Combines 5 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%14%
FOR: 55,489,041AGAINST: 8,757,025

Avadel Pharmaceuticals plc’s own tally for this item (“Proposal 3: To approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Acquisition”): 55,489,041 for, 8,757,025 against, per its Form 8-K filed 2026-01-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 97,235,000 outstanding shares: 57% for, 9% against (66% of the company cast a for/against vote).

The 218 asset managers below cast 90% of the shares they voted on this item FOR (57,595,117 for, 6,526,894 against).

FOR 90%10%
FOR: 57,595,117 (89.7%)AGAINST: 6,526,894 (10.2%)ABSTAIN: 120,769 (0.2%)
Largest asset managers voting on “ORDINARY RESOLUTION TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, SPECIFIED COMPENSATORY ARRANGEMENTS BETWEEN ” at Avadel Pharmaceuticals plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Janus Henderson7,710,1730 00For
BlackRock7,293,9360 00For
Vanguard5,522,7290 00For
Fidelity1,946,8062,822,777 00Against
TIG Advisors, LLC2,745,2510 00For
Vivo Capital, LLC2,684,1090 00For
BALYASNY ASSET MANAGEMENT L.P.2,398,8530 00For
GEODE CAPITAL MANAGEMENT, LLC2,193,9610 00For
State Street2,020,4782,901 00For
JANUS INVESTMENT FUND1,964,5230 00For
OAK RIDGE INVESTMENTS LLC1,684,0000 00For
Pentwater Capital Management LP1,684,0000 00For
Charles Schwab1,585,7670 00For
TUDOR INVESTMENT CORP ET AL1,573,1750 00For
Citadel1,393,5760 00For
HIGHBRIDGE CAPITAL MANAGEMENT LLC797,5210 00For
BRANDES INVESTMENT PARTNERS, LP0797,376 00Against
WATER ISLAND CAPITAL LLC796,7120 00For
Invesco780,2900 00For
Northern Trust28,206704,210 00Against
ARBITRAGE FUNDS722,7010 00For
Neuberger Berman664,8220 00For
Utah Retirement Systems603,7900 00For
Datum One Series Trust0594,902 00Against
DWS584,1160 00For

Showing the 25 largest of 218 asset managers. See all 218 in the interactive database.

2. ORDINARY RESOLUTION TO APPROVE ANY MOTION BY THE CHAIR TO ADJOURN THE EXTRAORDINARY GENERAL MEETING, OR ANY ADJOURNMENTS THEREOF, TO ANOTHER TIME AND PLACE IF NECESSARY OR APPROPRIATE TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES AT THE TIME OF THE EXTRAORDINARY GENERAL MEETING TO APPROVE RESOLUTIONS 1 AND 2.

CORPORATE GOVERNANCE

Meeting held 2026-01-12.

98% fund support · no official result

FOR 98%

The 55 asset managers below cast 98% of the shares they voted on this item FOR (17,383,677 for, 334,647 against).

FOR: 17,383,677 (97.7%)AGAINST: 334,647 (1.9%)ABSTAIN: 66,610 (0.4%)
Largest asset managers voting on “ORDINARY RESOLUTION TO APPROVE ANY MOTION BY THE CHAIR TO ADJOURN THE EXTRAORDINARY GENERAL MEETING, OR ANY AD” at Avadel Pharmaceuticals plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,759,2950 00For
BlackRock3,385,6800 00For
JANUS INVESTMENT FUND1,964,5230 00For
Fidelity1,939,6320 00For
Charles Schwab792,8110 00For
ARBITRAGE FUNDS722,7010 00For
Datum One Series Trust594,9020 00For
DWS582,4420 00For
TIAA499,3770 00For
First Trust490,4910 00For
Invesco362,3630 00For
State Street0256,813 00Against
Equitable137,6350 62,8000For
QUANTITATIVE MASTER SERIES LLC152,7180 00For
Janus Detroit Street Trust150,8630 00For
Lincoln Financial49,18463,700 00Against
Goldman Sachs97,6610 00For
Northern Trust56,8430 00For
Morningstar Funds Trust55,6040 00For
AQR49,2310 00For
PENN SERIES FUNDS INC44,3812,500 00For
Brighthouse42,1830 3,8100For
Voya45,8270 00For
AIG/SunAmerica43,6450 00For
Global X42,9160 00For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

3. SPECIAL RESOLUTION TO APPROVE AN AMENDMENT TO THE ARTICLES OF ASSOCIATION OF AVADEL SO THAT ANY AVADEL SHARES THAT ARE ISSUED ON OR AFTER THE VOTING RECORD TIME TO PERSONS OTHER THAN ALKERMES PLC OR ITS NOMINEE(S) WILL EITHER BE SUBJECT TO THE SCHEME OR WILL BE IMMEDIATELY AND AUTOMATICALLY ACQUIRED BY ALKERMES PLC AND/OR ITS NOMINEE(S) FOR THE SCHEME CONSIDERATION.

SHAREHOLDER RIGHTS AND DEFENSES

Meeting held 2026-01-12.

100% fund support · no official result

FOR 99.6%

The 55 asset managers below cast 100% of the shares they voted on this item FOR (17,718,324 for, 0 against).

FOR: 17,718,324 (99.6%)ABSTAIN: 66,610 (0.4%)
Largest asset managers voting on “SPECIAL RESOLUTION TO APPROVE AN AMENDMENT TO THE ARTICLES OF ASSOCIATION OF AVADEL SO THAT ANY AVADEL SHARES ” at Avadel Pharmaceuticals plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,759,2950 00For
BlackRock3,385,6800 00For
JANUS INVESTMENT FUND1,964,5230 00For
Fidelity1,939,6320 00For
Charles Schwab792,8110 00For
ARBITRAGE FUNDS722,7010 00For
Datum One Series Trust594,9020 00For
DWS582,4420 00For
TIAA499,3770 00For
First Trust490,4910 00For
Invesco362,3630 00For
State Street256,8130 00For
Equitable137,6350 62,8000For
QUANTITATIVE MASTER SERIES LLC152,7180 00For
Janus Detroit Street Trust150,8630 00For
Lincoln Financial112,8840 00For
Goldman Sachs97,6610 00For
Northern Trust56,8430 00For
Morningstar Funds Trust55,6040 00For
AQR49,2310 00For
PENN SERIES FUNDS INC46,8810 00For
Brighthouse42,1830 3,8100For
Voya45,8270 00For
AIG/SunAmerica43,6450 00For
Global X42,9160 00For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

4. Ordinary resolution to approve the Scheme and authorize the directors of Avadel Pharmaceuticals plc ("Avadel") to take all such actions as they consider necessary or appropriate for carrying the Scheme into effect.

EXTRAORDINARY TRANSACTIONS

Meeting held 2026-01-12.

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.6%

The 54 asset managers below cast 100% of the shares they voted on this item FOR (17,721,713 for, 0 against).

FOR: 17,721,713 (99.6%)ABSTAIN: 62,800 (0.4%)
Largest asset managers voting on “Ordinary resolution to approve the Scheme and authorize the directors of Avadel Pharmaceuticals plc ("Avadel")” at Avadel Pharmaceuticals plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,759,2950 00For
BlackRock3,385,6800 00For
JANUS INVESTMENT FUND1,964,5230 00For
Fidelity1,939,6320 00For
Charles Schwab792,8110 00For
ARBITRAGE FUNDS722,7010 00For
Datum One Series Trust594,9020 00For
DWS582,4420 00For
TIAA499,3770 00For
First Trust490,4910 00For
Invesco362,3630 00For
State Street256,8130 00For
Equitable137,6350 62,8000For
QUANTITATIVE MASTER SERIES LLC152,7180 00For
Janus Detroit Street Trust150,8630 00For
Lincoln Financial112,8840 00For
Goldman Sachs97,6610 00For
Northern Trust56,8430 00For
Morningstar Funds Trust55,6040 00For
AQR49,2310 00For
PENN SERIES FUNDS INC46,8810 00For
Brighthouse45,9930 00For
Voya45,8270 00For
AIG/SunAmerica43,6450 00For
Global X42,9160 00For

Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.

5. Election of Directors: Dr. Eric J. Ende

DIRECTOR ELECTIONS

Meeting held 2025-07-29; no official results are on file for this meeting.

Combines 3 wordings of this item as funds reported it.

98% fund support · no official result

FOR 98%

The 41 asset managers below cast 98% of the shares they voted on this item FOR (14,719,678 for, 232,854 against).

FOR: 14,719,678 (98.0%)AGAINST: 232,854 (1.6%)ABSTAIN: 61,400 (0.4%)
Largest asset managers voting on “Election of Directors: Dr. Eric J. Ende” at Avadel Pharmaceuticals plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND3,934,1410 00For
Vanguard3,846,1210 00For
BlackRock2,686,0170 00For
Fidelity1,377,2600 00For
Datum One Series Trust1,284,9430 00For
DWS439,4530 00For
Charles Schwab229,8510 00For
Equitable151,0950 61,4000For
TIAA0198,136 00Against
Morgan Stanley104,9170 00For
Lincoln Financial68,7000 00For
Global X55,4660 00For
PENN SERIES FUNDS INC52,6910 00For
AIG/SunAmerica50,5670 00For
Goldman Sachs42,7350 00For
Northern Trust42,5380 00For
State Street39,8180 00For
MUTUAL FUND SERIES TRUST37,4330 00For
Royce35,4600 00For
STEWARD FUNDS, INC.35,0080 00For
JPMorgan33,4960 00For
John Hancock31,4320 00For
Pacific Life28,3550 00For
ProShares20,8380 00For
Bridge Builder Trust19,0920 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

6. Election of Directors: Dr. Mark A. McCamish

DIRECTOR ELECTIONS

Meeting held 2025-07-29; no official results are on file for this meeting.

Combines 4 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 41 asset managers below cast 99.9% of the shares they voted on this item FOR (15,013,551 for, 381 against).

FOR: 15,013,551 (100.0%)AGAINST: 381 (0.0%)
Largest asset managers voting on “Election of Directors: Dr. Mark A. McCamish” at Avadel Pharmaceuticals plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND3,934,1410 00For
Vanguard3,846,1210 00For
BlackRock2,686,0170 00For
Fidelity1,377,2600 00For
Datum One Series Trust1,284,9430 00For
DWS439,4530 00For
Charles Schwab229,8510 00For
Equitable212,4950 00For
TIAA198,1360 00For
Morgan Stanley104,9170 00For
Lincoln Financial68,7000 00For
Global X55,4660 00For
PENN SERIES FUNDS INC52,6910 00For
AIG/SunAmerica50,5670 00For
Goldman Sachs42,7350 00For
Northern Trust42,5380 00For
State Street39,8180 00For
MUTUAL FUND SERIES TRUST37,4330 00For
Royce35,4600 00For
STEWARD FUNDS, INC.35,0080 00For
JPMorgan33,4960 00For
John Hancock31,4320 00For
Pacific Life28,3550 00For
ProShares20,8380 00For
Bridge Builder Trust19,0920 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

7. Election of Directors: Dr. Naseem S. Amin

DIRECTOR ELECTIONS

Meeting held 2025-07-29; no official results are on file for this meeting.

Combines 3 wordings of this item as funds reported it.

99% fund support · no official result

FOR 98%

The 41 asset managers below cast 99% of the shares they voted on this item FOR (14,737,060 for, 215,472 against).

FOR: 14,737,060 (98.2%)AGAINST: 215,472 (1.4%)ABSTAIN: 61,400 (0.4%)
Largest asset managers voting on “Election of Directors: Dr. Naseem S. Amin” at Avadel Pharmaceuticals plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND3,934,1410 00For
Vanguard3,846,1210 00For
BlackRock2,686,0170 00For
Fidelity1,377,2600 00For
Datum One Series Trust1,284,9430 00For
DWS439,4530 00For
Charles Schwab229,8510 00For
Equitable151,0950 61,4000For
TIAA0198,136 00Against
Morgan Stanley104,9170 00For
Lincoln Financial68,7000 00For
Global X55,4660 00For
PENN SERIES FUNDS INC52,6910 00For
AIG/SunAmerica50,5670 00For
Goldman Sachs42,7350 00For
Northern Trust42,5380 00For
State Street39,8180 00For
MUTUAL FUND SERIES TRUST37,4330 00For
Royce35,4600 00For
STEWARD FUNDS, INC.35,0080 00For
JPMorgan33,4960 00For
John Hancock31,4320 00For
Pacific Life28,3550 00For
ProShares20,8380 00For
Bridge Builder Trust19,0920 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

8. Election of Directors: Geoffrey M. Glass

DIRECTOR ELECTIONS

Meeting held 2025-07-29; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

99% fund support · no official result

FOR 98%

The 41 asset managers below cast 99% of the shares they voted on this item FOR (14,737,441 for, 215,091 against).

FOR: 14,737,441 (98.2%)AGAINST: 215,091 (1.4%)ABSTAIN: 61,400 (0.4%)
Largest asset managers voting on “Election of Directors: Geoffrey M. Glass” at Avadel Pharmaceuticals plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND3,934,1410 00For
Vanguard3,846,1210 00For
BlackRock2,686,0170 00For
Fidelity1,377,2600 00For
Datum One Series Trust1,284,9430 00For
DWS439,4530 00For
Charles Schwab229,8510 00For
Equitable151,0950 61,4000For
TIAA0198,136 00Against
Morgan Stanley104,9170 00For
Lincoln Financial68,7000 00For
Global X55,4660 00For
PENN SERIES FUNDS INC52,6910 00For
AIG/SunAmerica50,5670 00For
Goldman Sachs42,7350 00For
Northern Trust42,5380 00For
State Street39,8180 00For
MUTUAL FUND SERIES TRUST37,4330 00For
Royce35,4600 00For
STEWARD FUNDS, INC.35,0080 00For
JPMorgan33,4960 00For
John Hancock31,4320 00For
Pacific Life28,3550 00For
ProShares20,8380 00For
Bridge Builder Trust19,0920 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

9. Election of Directors: Gregory J. Divis

DIRECTOR ELECTIONS

Meeting held 2025-07-29; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 41 asset managers below cast 100% of the shares they voted on this item FOR (15,013,932 for, 0 against).

FOR: 15,013,932 (100.0%)
Largest asset managers voting on “Election of Directors: Gregory J. Divis” at Avadel Pharmaceuticals plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND3,934,1410 00For
Vanguard3,846,1210 00For
BlackRock2,686,0170 00For
Fidelity1,377,2600 00For
Datum One Series Trust1,284,9430 00For
DWS439,4530 00For
Charles Schwab229,8510 00For
Equitable212,4950 00For
TIAA198,1360 00For
Morgan Stanley104,9170 00For
Lincoln Financial68,7000 00For
Global X55,4660 00For
PENN SERIES FUNDS INC52,6910 00For
AIG/SunAmerica50,5670 00For
Goldman Sachs42,7350 00For
Northern Trust42,5380 00For
State Street39,8180 00For
MUTUAL FUND SERIES TRUST37,4330 00For
Royce35,4600 00For
STEWARD FUNDS, INC.35,0080 00For
JPMorgan33,4960 00For
John Hancock31,4320 00For
Pacific Life28,3550 00For
ProShares20,8380 00For
Bridge Builder Trust19,0920 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

10. Election of Directors: Linda S. Palczuk

DIRECTOR ELECTIONS

Meeting held 2025-07-29; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

99% fund support · no official result

FOR 98%

The 41 asset managers below cast 99% of the shares they voted on this item FOR (14,737,060 for, 215,472 against).

FOR: 14,737,060 (98.2%)AGAINST: 215,472 (1.4%)ABSTAIN: 61,400 (0.4%)
Largest asset managers voting on “Election of Directors: Linda S. Palczuk” at Avadel Pharmaceuticals plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND3,934,1410 00For
Vanguard3,846,1210 00For
BlackRock2,686,0170 00For
Fidelity1,377,2600 00For
Datum One Series Trust1,284,9430 00For
DWS439,4530 00For
Charles Schwab229,8510 00For
Equitable151,0950 61,4000For
TIAA0198,136 00Against
Morgan Stanley104,9170 00For
Lincoln Financial68,7000 00For
Global X55,4660 00For
PENN SERIES FUNDS INC52,6910 00For
AIG/SunAmerica50,5670 00For
Goldman Sachs42,7350 00For
Northern Trust42,5380 00For
State Street39,8180 00For
MUTUAL FUND SERIES TRUST37,4330 00For
Royce35,4600 00For
STEWARD FUNDS, INC.35,0080 00For
JPMorgan33,4960 00For
John Hancock31,4320 00For
Pacific Life28,3550 00For
ProShares20,8380 00For
Bridge Builder Trust19,0920 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

11. Election of Directors: Peter J. Thornton

DIRECTOR ELECTIONS

Meeting held 2025-07-29; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 41 asset managers below cast 99.9% of the shares they voted on this item FOR (15,013,551 for, 381 against).

FOR: 15,013,551 (100.0%)AGAINST: 381 (0.0%)
Largest asset managers voting on “Election of Directors: Peter J. Thornton” at Avadel Pharmaceuticals plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND3,934,1410 00For
Vanguard3,846,1210 00For
BlackRock2,686,0170 00For
Fidelity1,377,2600 00For
Datum One Series Trust1,284,9430 00For
DWS439,4530 00For
Charles Schwab229,8510 00For
Equitable212,4950 00For
TIAA198,1360 00For
Morgan Stanley104,9170 00For
Lincoln Financial68,7000 00For
Global X55,4660 00For
PENN SERIES FUNDS INC52,6910 00For
AIG/SunAmerica50,5670 00For
Goldman Sachs42,7350 00For
Northern Trust42,5380 00For
State Street39,8180 00For
MUTUAL FUND SERIES TRUST37,4330 00For
Royce35,4600 00For
STEWARD FUNDS, INC.35,0080 00For
JPMorgan33,4960 00For
John Hancock31,4320 00For
Pacific Life28,3550 00For
ProShares20,8380 00For
Bridge Builder Trust19,0920 00For

Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.

12. TO RATIFY, ON A NON-BINDING ADVISORY BASIS, THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC AUDITOR AND ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025, AND TO AUTHORIZE, IN A BINDING VOTE, THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS TO SET THE INDEPENDENT REGISTERED PUBLIC AUDITOR AND ACCOUNTING FIRM REMUNERATION

AUDIT-RELATED

Meeting held 2025-07-29; no official results are on file for this meeting.

100% fund support · no official result

FOR 100%

The 40 asset managers below cast 100% of the shares they voted on this item FOR (14,980,436 for, 0 against).

FOR: 14,980,436 (100.0%)
Largest asset managers voting on “TO RATIFY, ON A NON-BINDING ADVISORY BASIS, THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPEND” at Avadel Pharmaceuticals plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND3,934,1410 00For
Vanguard3,846,1210 00For
BlackRock2,686,0170 00For
Fidelity1,377,2600 00For
Datum One Series Trust1,284,9430 00For
DWS439,4530 00For
Charles Schwab229,8510 00For
Equitable212,4950 00For
TIAA198,1360 00For
Morgan Stanley104,9170 00For
Lincoln Financial68,7000 00For
Global X55,4660 00For
PENN SERIES FUNDS INC52,6910 00For
AIG/SunAmerica50,5670 00For
Goldman Sachs42,7350 00For
Northern Trust42,5380 00For
State Street39,8180 00For
MUTUAL FUND SERIES TRUST37,4330 00For
Royce35,4600 00For
STEWARD FUNDS, INC.35,0080 00For
John Hancock31,4320 00For
Pacific Life28,3550 00For
ProShares20,8380 00For
Bridge Builder Trust19,0920 00For
Nationwide18,8020 00For

Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.

13. THAT THE SCHEME IN ITS ORIGINAL FORM OR WITH OR SUBJECT TO ANY MODIFICATION(S), ADDITION(S) OR CONDITION(S) APPROVED OR IMPOSED BY THE IRISH HIGH COURT BE AGREED TO.

OTHER

Meeting held 2026-01-12.

100% fund support · no official result

FOR 99.4%

The 35 asset managers below cast 100% of the shares they voted on this item FOR (11,838,795 for, 0 against).

FOR: 11,838,795 (99.5%)ABSTAIN: 62,800 (0.5%)
Largest asset managers voting on “THAT THE SCHEME IN ITS ORIGINAL FORM OR WITH OR SUBJECT TO ANY MODIFICATION(S), ADDITION(S) OR CONDITION(S) AP” at Avadel Pharmaceuticals plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,759,2950 00For
JANUS INVESTMENT FUND1,964,5230 00For
Fidelity1,939,6320 00For
DWS582,4420 00For
TIAA499,3770 00For
First Trust490,4910 00For
Invesco362,3630 00For
State Street256,8130 00For
Equitable137,6350 62,8000For
Janus Detroit Street Trust150,8630 00For
Lincoln Financial112,8840 00For
Goldman Sachs90,4350 00For
Northern Trust56,8430 00For
AQR49,2310 00For
PENN SERIES FUNDS INC46,8810 00For
Voya45,8270 00For
AIG/SunAmerica43,6450 00For
Brighthouse42,1830 00For
MUTUAL FUND SERIES TRUST37,6930 00For
ProShares34,5200 00For
Pacific Life26,8540 00For
Nationwide25,1630 00For
Virtus16,3850 00For
Direxion Shares ETF Trust12,3490 00For
T. Rowe Price9,2240 00For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

14. THAT, ANY MOTION BY THE CHAIR TO ADJOURN THE SCHEME MEETING, OR ANY ADJOURNMENTS THEREOF, TO ANOTHER TIME AND PLACE IF NECESSARY OR APPROPRIATE TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES AT THE TIME OF THE SCHEME MEETING TO APPROVE THE SCHEME, BE APPROVED.

CORPORATE GOVERNANCE

Meeting held 2026-01-12.

97% fund support · no official result

FOR 97%

The 35 asset managers below cast 97% of the shares they voted on this item FOR (11,504,148 for, 334,647 against).

FOR: 11,504,148 (96.7%)AGAINST: 334,647 (2.8%)ABSTAIN: 62,800 (0.5%)
Largest asset managers voting on “THAT, ANY MOTION BY THE CHAIR TO ADJOURN THE SCHEME MEETING, OR ANY ADJOURNMENTS THEREOF, TO ANOTHER TIME AND ” at Avadel Pharmaceuticals plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,759,2950 00For
JANUS INVESTMENT FUND1,964,5230 00For
Fidelity1,939,6320 00For
DWS582,4420 00For
TIAA499,3770 00For
First Trust490,4910 00For
Invesco362,3630 00For
State Street0256,813 00Against
Equitable137,6350 62,8000For
Janus Detroit Street Trust150,8630 00For
Lincoln Financial49,18463,700 00Against
Goldman Sachs90,4350 00For
Northern Trust56,8430 00For
AQR49,2310 00For
PENN SERIES FUNDS INC44,3812,500 00For
Voya45,8270 00For
AIG/SunAmerica43,6450 00For
Brighthouse42,1830 00For
MUTUAL FUND SERIES TRUST37,6930 00For
ProShares34,5200 00For
Pacific Life26,8540 00For
Nationwide25,1630 00For
Virtus16,3850 00For
Direxion Shares ETF Trust12,3490 00For
T. Rowe Price09,224 00Against

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

15. Advisory Vote on Golden Parachutes

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2026-01-12.

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 5 asset managers below cast 100% of the shares they voted on this item FOR (397,605 for, 0 against).

FOR: 397,605 (100.0%)
Largest asset managers voting on “Advisory Vote on Golden Parachutes” at Avadel Pharmaceuticals plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
JPMorgan208,5220 00For
WEXFORD CAPITAL LP150,0000 00For
Lincoln Financial37,8410 00For
TD Waterhouse Canada Inc.1,2420 00For
Taconic Capital Advisors LP00 00--

16. Adjourn Meeting

CORPORATE GOVERNANCE

Meeting held 2026-01-12.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (492,726 for, 0 against).

FOR: 492,726 (100.0%)
Largest asset managers voting on “Adjourn Meeting” at Avadel Pharmaceuticals plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
JPMorgan417,0440 00For
Lincoln Financial75,6820 00For

17. Amend Articles of Association

CORPORATE GOVERNANCEMajority of the votes cast: yes

Meeting held 2026-01-12.

96% Majority: yes · of votes cast

FOR 96%
FOR: 61,808,690AGAINST: 2,673,461

Avadel Pharmaceuticals plc’s own tally for this item (“Proposal 2: To amend the Articles of Association of Avadel so that any ordinary shares of Avadel that are issued on or after the voting record time to persons other than Alkermes or its nominee(s) will either be subject ”): 61,808,690 for, 2,673,461 against, per its Form 8-K filed 2026-01-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 97,235,000 outstanding shares: 64% for, 3% against (66% of the company cast a for/against vote).

The 2 asset managers below cast 100% of the shares they voted on this item FOR (246,363 for, 0 against).

FOR 100%
FOR: 246,363 (100.0%)
Largest asset managers voting on “Amend Articles of Association” at Avadel Pharmaceuticals plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
JPMorgan208,5220 00For
Lincoln Financial37,8410 00For

18. Approve Scheme of Arrangement

EXTRAORDINARY TRANSACTIONS

Meeting held 2026-01-12.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (492,726 for, 0 against).

FOR: 492,726 (100.0%)
Largest asset managers voting on “Approve Scheme of Arrangement” at Avadel Pharmaceuticals plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
JPMorgan417,0440 00For
Lincoln Financial75,6820 00For

Largest Avadel Pharmaceuticals plc shareholders voting in 2025-2026

Ranked by the number of Avadel Pharmaceuticals plc shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 97,235,000 shares outstanding at the time of that meeting.

Top Avadel Pharmaceuticals plc shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Janus Henderson 7.93%
2BlackRock 7.50%
3Vanguard 5.68%
4Fidelity 4.91%
5TIG Advisors, LLC 2.82%
6Vivo Capital, LLC 2.76%
7BALYASNY ASSET MANAGEMENT L.P. 2.47%
8GEODE CAPITAL MANAGEMENT, LLC 2.26%
9State Street 2.08%
10JANUS INVESTMENT FUND 2.02%

Reported Avadel Pharmaceuticals plc ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Avadel Pharmaceuticals plc beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
Vanguard Group 6.03% 13F
Jeffrey L. Gendell 4.98% 13G
JANUS HENDERSON GROUP PLC 1.88% 13G
Morgan Stanley 0.54% 13F
BRANDES INVESTMENT PARTNERS, LP 0.23% 13G

Percentages above are of 97,235,000 shares outstanding, as reported by Avadel Pharmaceuticals plc on its Form 10-Q dated 2025-09-30 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Avadel Pharmaceuticals plc’s 10-Q dated 2025-09-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Avadel Pharmaceuticals plc's 2 shareholder meetings in the 2025-2026 proxy season (held 2025-07-29 and 2026-01-12), 229 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,763 separate fund positions. Their filings are grouped here into 18 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held 2026-01-12 — ORDINARY RESOLUTION TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, SPECIFIED COMPENSATORY… — FOR was 86% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Avadel Pharmaceuticals plc's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-01-12.

Avadel Pharmaceuticals plc proxy season coverage: 2024-2025 · 2025-2026 (this page).